Drug Type Small molecule drug |
Synonyms NBI 30545, NBI-30545 |
Target |
Action antagonists |
Mechanism CRHR1 antagonists(Corticotropin-releasing factor receptor 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N4O3 |
InChIKeyAKFWXFDMKRSYRD-UHFFFAOYSA-N |
CAS Registry195054-99-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Discovery | United States | 01 Jul 2004 | |
| Depressive Disorder | Discovery | United States | 01 Jul 2004 | |
| Stroke | Discovery | United States | - |





